The approval is based on global Phase III QUANTI studies evaluating Ambelvist's efficacy and safety in adults and children.

Although contrast agents have an essential role in non-invasive imaging techniques, potential side effects limit their use. For example, both low- and iso-osmolar iodinated contrast media used in ...

The FDA has cleared several oncology products over the past few days, ranging from therapies to diagnostic and imaging tools.

A specially coated iron oxide nanoparticle could provide an alternative to conventional gadolinium-based contrast agents used for magnetic resonance imaging (MRI). In rare cases, the currently used ...

The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.

A group of researchers led by Leif Schroeder from the Leibniz-Forschungsinstitut fuer Molekulare Pharmakologie (FMP) have found a way to detect metastases in certain types of cancer in the brain at an ...

Skoltech researchers and their colleagues have synthesized and tested protein-polymer microbubbles for use in medical ultrasound imaging of internal organs. Administered intravenously, the ...

To enhance the visibility of organs as they are scanned with magnetic resonance imaging (MRI), patients are usually injected with a compound known as a contrast agent before going into the scanner.

NEW ORLEANS ― For patients with suspected coronary artery disease, the intravenous administration of a contrast agent during angiography is safer and faster than intra-arterial administration, a ...

The top causes of death worldwide, ischemic heart diseases and stroke, together with another major source of illness, that is cancer, require proper imaging of blood vessels. A team formed by the ...

Researchers have taken a key step forward in developing a new, possibly safer contrast agent for use in MRI exams. Researchers at Massachusetts General Hospital (MGH) have taken a key step forward in ...